New Approaches to Microbiome-Based Therapies
ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b096209cbfcb48809b097e57ef319385 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b096209cbfcb48809b097e57ef319385 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b096209cbfcb48809b097e57ef3193852021-12-02T18:44:39ZNew Approaches to Microbiome-Based Therapies10.1128/mSystems.00122-192379-5077https://doaj.org/article/b096209cbfcb48809b097e57ef3193852019-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00122-19https://doaj.org/toc/2379-5077ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the microbiome to human health. Consequently, the intestinal microbiota has emerged as an attractive therapeutic target. The large majority of microbiota-targeted therapies aim at engineering the intestinal ecosystem by means of probiotics or prebiotics. Recently, a novel therapeutic approach has emerged which focuses on molecules that are secreted, modulated, or degraded by the microbiome and act directly on the host. Here, we discuss the advantages and challenges associated with the metabolite-based “postbiotic” approach, highlighting recent progress and the areas that need intensive attention and investigation over the next 5 years. The time is ripe for postbiotic therapies to be developed in the near future.Andrea C. WongMaayan LevyAmerican Society for Microbiologyarticlegnotobioticsmetabolitesmetagenomicsmicrobiomemicrobiome-based therapiespostbioticsMicrobiologyQR1-502ENmSystems, Vol 4, Iss 3 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
gnotobiotics metabolites metagenomics microbiome microbiome-based therapies postbiotics Microbiology QR1-502 |
spellingShingle |
gnotobiotics metabolites metagenomics microbiome microbiome-based therapies postbiotics Microbiology QR1-502 Andrea C. Wong Maayan Levy New Approaches to Microbiome-Based Therapies |
description |
ABSTRACT Over the last decade, our understanding of the composition and functions of the gut microbiota has greatly increased. To a large extent, this has been due to the development of high-throughput genomic analyses of microbial communities, which have identified the critical contributions of the microbiome to human health. Consequently, the intestinal microbiota has emerged as an attractive therapeutic target. The large majority of microbiota-targeted therapies aim at engineering the intestinal ecosystem by means of probiotics or prebiotics. Recently, a novel therapeutic approach has emerged which focuses on molecules that are secreted, modulated, or degraded by the microbiome and act directly on the host. Here, we discuss the advantages and challenges associated with the metabolite-based “postbiotic” approach, highlighting recent progress and the areas that need intensive attention and investigation over the next 5 years. The time is ripe for postbiotic therapies to be developed in the near future. |
format |
article |
author |
Andrea C. Wong Maayan Levy |
author_facet |
Andrea C. Wong Maayan Levy |
author_sort |
Andrea C. Wong |
title |
New Approaches to Microbiome-Based Therapies |
title_short |
New Approaches to Microbiome-Based Therapies |
title_full |
New Approaches to Microbiome-Based Therapies |
title_fullStr |
New Approaches to Microbiome-Based Therapies |
title_full_unstemmed |
New Approaches to Microbiome-Based Therapies |
title_sort |
new approaches to microbiome-based therapies |
publisher |
American Society for Microbiology |
publishDate |
2019 |
url |
https://doaj.org/article/b096209cbfcb48809b097e57ef319385 |
work_keys_str_mv |
AT andreacwong newapproachestomicrobiomebasedtherapies AT maayanlevy newapproachestomicrobiomebasedtherapies |
_version_ |
1718377699360112640 |